A new study published 14 June in JAMA Psychiatry has found evidence that supplementing the diet with a probiotic blend containing 14 strains of bacteria can help individuals who are being treated for major depressive disorder with antidepressants. The research, led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and in partnership with ADM Protexin, part of ADM, demonstrated the potential of probiotic supplementation to support improvements in multiple depression and anxiety scores over an eight-week period. The pilot study is one of the first trials in a Western population to show both good tolerability...